# Comparison of Anyu Peibo With Placebo in Treatment of MDD in China

> **NCT04210973** · PHASE3 · UNKNOWN · sponsor: **Shanghai Mental Health Center** · enrollment: 266 (estimated)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** Anyu Peibo
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04210973
- **Lead sponsor:** Shanghai Mental Health Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-01-23
- **Primary completion:** 2020-12
- **Final completion:** 2021-05
- **Target enrollment:** 266 (ESTIMATED)
- **Last updated:** 2020-05-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04210973

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04210973, "Comparison of Anyu Peibo With Placebo in Treatment of MDD in China". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT04210973. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*